British In Vitro Diagnostics Association

What British In Vitro Diagnostics Association does

The British In Vitro Diagnostics Association (BIVDA) is the UK national trade association for manufacturers and distributors of in vitro diagnostic (IVD) medical devices, operating as BIVDA Ltd, a private limited company registered in England (Company Number 2687137) and headquartered at 299 Oxford Street (5th floor), London. Founded in 1992 and operating with a small core staff of 1–10 employees, BIVDA represents 97% of the UK IVD industry and approximately 250 member organisations spanning an industry that employs more than 20,000 people in the UK and generates annual turnover of approximately £3.5 billion.

BIVDA's operational scope is advocacy, regulatory advisory, and member services rather than product development. Core offerings include (i) membership services with tiered benefits, exclusive publications (magazine and newsletters), and a member portal; (ii) the annual Regulatory Affairs Seminar, hosted in Birmingham and featuring MHRA leadership; (iii) working party and External Affairs meetings on regulatory, policy, and parliamentary engagement topics; (iv) the UK Responsible Person Directory, a compliance resource aiding members with IVDR transition; and (v) Insights & Analysis, Facts & Figures, and FAQs providing market intelligence. The association's strategic partners include NHS England, MHRA, the Accelerated Access Collaborative, Cancer Research UK, King's Fund, ABPI, MedTech Europe, Health Innovation Network and NHSX, with structured engagement on the NHS 10-Year Plan, Life Sciences Sector Plan, and MedTech Funding Mandate.

BIVDA's revenue model is subscription-recurring membership fees from IVD manufacturers and distributors, with tiered membership and quote-based pricing that is not publicly disclosed (applications are screened and approved by the Site Administrator). All revenue is domestic UK, with no disclosed international operations. The leadership team comprises Doris-Ann Williams (Chief Executive), Helen Dent (Chief Operating Officer), David Thorne (Head of NHS Policy, appointed December 2025), Paul Fisher (Director of Policy and Programmes), Jon Harrison (External Affairs Manager), and Senior Leadership Team members Beth Loudon, Angela Douglas, and Professor Mike Messenger.

Name

British In Vitro Diagnostics Association

Legal name

BIVDA Ltd

Website

https://bivda.org.uk

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

1–10 employees

Short description

BIVDA is the UK national trade association for in vitro diagnostics manufacturers and distributors, representing 97% of the UK IVD industry and nearly 250 member organisations through advocacy, regulatory guidance, events, and policy engagement with NHS England and MHRA.

Ownership category

akta.pro rank

Product category

Industry Trade Association Services

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

akta.pro secondary industry

In Vitro Diagnostics (IVD) Regulators (HLAJADAD)

Keywords

• In vitro diagnostics
• IVD trade association
• Diagnostic industry advocacy
• Medical device representation
• UK Responsible Person services

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Membership Fees: BIVDA generates revenue primarily through membership fees from IVD manufacturers and distributors. The association provides member benefits including advocacy, regulatory support, publications, magazine access, and networking services.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

BIVDA is the UK trade association that represents manufacturers, distributors, and suppliers of in vitro diagnostic (IVD) medical devices and reagents. Founded in 1992, it delivers collective industry advocacy, regulatory engagement with the MHRA and NHS, networking events, the UK Responsible Person Directory supporting IVDR compliance, and policy Insights & Analysis to its member companies operating in the UK diagnostics market.

Product overview

BIVDA is a trade association representing manufacturers and distributors of in vitro diagnostic tests in the UK, covering 97% of the industry and nearly 250 organisations. Rather than operating a product business, BIVDA provides membership services including exclusive publications (magazine and newsletters), organizes the annual Regulatory Affairs Seminar, maintains the UK Responsible Person Directory, and offers Insights & Analysis resources. The association serves as an advocacy and support organization for the UK diagnostic testing sector.

Differentiator

Problem solved

Functional benefit

Products and services

• IVDA Membership Annual paid membership for IVD manufacturers, distributors, and suppliers operating in the UK, granting access to advocacy, regulatory support, events, and member resources.
• Industry Seminars and Networking Events Conferences, seminars, and networking forums bringing together UK IVD manufacturers, distributors, regulators, and NHS stakeholders to discuss regulatory, clinical, and commercial topics.
• UK Responsible Person Directory A directory resource supporting IVD manufacturers in identifying and appointing UK Responsible Persons to comply with post-Brexit IVDR requirements for placing IVD products on the GB market.
• Insights & Analysis Reporting Industry-level data, policy, and market Insights & Analysis reports delivered to members covering UK IVD regulatory developments, NHS procurement trends, and legislative updates.

Quantifiable outcome

• Representing 97% of the UK IVD industry with nearly 250 member organisations
• +2 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Ten partnerships are on record, tiered major and core.

• King's FundmajorStrategic or Co-development Partner · 26 September 2025BIVDA collaborated with King's Fund and ABPI to develop the Life Sciences Explainer, released in September 2025. The explainer provides an overview of the life sciences sector for policymakers and stakeholders.
• Professor Sir Chris Whitty (Chief Medical Officer)coreStrategic or Co-development Partner · 2 September 2025BIVDA chaired a meeting between Professor Sir Chris Whitty and BIVDA members involved in the industry consensus statement 'Unlocking Our Communities Diagnostic Potential.' The meeting addressed opportunities to support adoption of point-of-care testing in primary care and community care settings.
• NHS EnglandcoreStrategic or Co-development PartnerBIVDA works closely with NHS England on policy development, NHS 10-Year Plan implementation, Life Sciences Sector Plan, MedTech Funding Mandate, and NHS Carbon Reduction Plan guidance. BIVDA's Head of NHS Policy David Thorne is part of the BIVDA Senior Leadership Team working to promote and improve uptake of diagnostics and innovation across the NHS.
• MHRA (Medicines and Healthcare products Regulatory Agency)coreStrategic or Co-development PartnerBIVDA coordinates with MHRA on regulatory affairs including IVDR implementation, COVID-19 testing device authorisations, and participates in industry discussions on regulatory guidance. MHRA Chief Executive Lawrence Tallon delivers keynote addresses at BIVDA events.
• Cancer Research UKmajorStrategic or Co-development PartnerBIVDA participates in Cancer Research UK's Early Detection and Diagnosis Roadmap, a campaign to make early detection of cancers a reality within the NHS and address challenges including low uptake of diagnostics, regulatory hurdles, and lack of market incentives for early diagnosis products.
• MedTech EuropecoreChannel Partner/ Reseller/ DistributorBIVDA participates in MedTech Europe activities including IVD market surveys conducted on behalf of the European Commission. MedTech Europe represents the European medical technology industry including in vitro diagnostics.
• Accelerated Access Collaborative (AAC)coreStrategic or Co-development PartnerBIVDA is a member of the AAC, hosted by NHS England and NHS Improvement. The collaborative brings together industry, government, regulators, patients and NHS to accelerate adoption of innovations. BIVDA participates in working groups and supports MedTech Funding Mandate development.
• All Party Group for Life SciencesmajorStrategic or Co-development PartnerBIVDA co-provides the secretariat for the All Party Group for Life Sciences, which addresses adoption support schemes for IVDs and other life sciences policy issues.
• Health Innovation NetworkmajorStrategic or Co-development PartnerBIVDA's Director of Policy and Programmes Paul Fisher contributed a guest blog on the value of diagnostics for the Health Innovation Network, advocating for new approaches to assessing diagnostic value in health systems.
• NHSXmajorStrategic or Co-development PartnerBIVDA works with NHSX on AI surveys and digital health technology assessment criteria (DTAC). NHSX collaborated with AHSN Network on surveys regarding AI development and implementation in health and care.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• MedTech Europe: European-level trade association for the medical technology industry including IVDs. BIVDA partners with MedTech Europe and participates in its IVD market surveys on behalf of the European Commission, making it the closest supranational peer and a partner/competitor on UK-EU IVD regulatory matters.
• AdvaMed (Advanced Medical Technology Association): Leading US medical device and diagnostics industry association. Comparable in function to BIVDA as a national industry body advocating for medtech/IVD members, though larger and focused on the US market.

Emerging players

• APACMed (Asia Pacific Medical Technology Association): Regional industry association representing medical device and IVD companies across Asia Pacific. Functionally analogous to BIVDA but for the APAC region, with similar advocacy, regulatory, and member-service mandate.

Regional players

• MedTech Canada: National trade association for the Canadian medical device and IVD industry. Direct functional peer to BIVDA at the national level — same member-base structure, regulatory advocacy, and government engagement model.
• SNITEM (Syndicat National de l'Industrie des Technologies Médicales): French national industry association for medical devices, including IVDs. Direct European peer to BIVDA in mission and structure, representing manufacturers in regulatory and reimbursement discussions with French authorities.
• BVMed (Bundesverband Medizintechnologie): German medical technology industry association covering IVDs. Comparable to BIVDA as a national advocacy body engaging with regulators and government, with a similar membership and event-driven operating model.
• Swiss Medtech: Swiss medical technology industry association. Peer to BIVDA in function, representing IVD and medtech manufacturers domestically and engaging with EU/MHRA-equivalent regulators on cross-border issues.
• JFMDA (Japan Federation of Medical Devices Associations): Japanese medical device industry federation. Comparable in mission to BIVDA — representing manufacturers in regulatory and policy forums — though much larger and operating in a distinct regulatory environment.

Direct peers

• ABHI (Association of British HealthTech Industries): UK industry association for health technology, including medical devices. Most direct functional peer to BIVDA in the UK, also engaging with NHS England, MHRA and DHSC on medtech policy, regulatory affairs, and member services.

Others

• BioIndustry Association (BIA): UK trade association for the broader life sciences and biotech sector. Adjacent rather than direct competitor, but overlaps with BIVDA on UK life sciences policy advocacy, NHS innovation engagement, and the Life Sciences Explainer work alongside King's Fund.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/BIVDA
• Facebookfacebook.com/British-In-Vitro-Diagnostics-Association-104048751724774
• LinkedInlinkedin.com/company/british-in-vitro-diagnostics-association

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about British In Vitro Diagnostics Association